The Effect of Delayed Cancer Screening on Stage Shift and Increased Mortality during the Coronapandemic in The Netherlands

  • Funded by Netherlands Organisation for Health Research and Development (ZonMW)
  • Total publications:0 publications

Grant number: 1.04303E+13

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2023
  • Funder

    Netherlands Organisation for Health Research and Development (ZonMW)
  • Principal Investigator

    dr. prof RWJ Meester
  • Research Location

    Netherlands
  • Lead Research Institution

    Vrije Universiteit Amsterdam
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

We investigated to what extent the temporary stop of cancer screening (breast cancer, colon cancer and cervical cancer) during the Covid-19 pandemic contributed to excess mortality in 2020 and 2021. Based on a lot of data (all open), we concluded that it is highly unlikely that this temporary screening stop had a significant effect on excess mortality in the period mentioned. The cause of this excess mortality must therefore be sought elsewhere. We were able to draw this conclusion based on a careful analysis of the available data. We emphatically do not claim that the screening stop has not been without consequences for anyone: we were not able to use data at patient level, so we cannot draw such a conclusion. We do not comment on the consequences of the screening stop in the longer term.